AtlasClear: A Growing Clearinghouse With a Delisting Problem
Revenue rose 27% and stock locate became half the business, but NYSE American suspended the shares—and the reverse split now matters more than the P&L.
ATCH · Earnings Call · 2026-11-16
The P&L is moving; the listing is not
AtlasClear's fiscal Q1 2027 call is a split-screen. The operating business is small but growing: revenue rose 27% to $5.4 million, total revenue plus interest income reached $5.9 million, and stock locate contributed $3 million—more than half the top line and close to half of what it generated in all of fiscal 2026. AtlasClearing ended the quarter with $15.2 million of net capital, up from $14.4 million, and the company has signed nine correspondent broker dealer agreements, four of them since July.
Then there is the equity. On November 10, the staff of the NYSE American suspended trading in the common stock and began delisting proceedings over the low selling price. The shares now quote on OTC at roughly $0.07, giving the company an $8.96 million market cap against $20.7 million of stockholders' equity. The tape is ugly even by penny-stock standards: down 73% in 90 trading days, with a 55% drop in the last four sessions, and a 75% drawdown from the May peak. The appeal process and a potential reverse split are now the most important things management discussed.
This is not a fundamental-based decision. This is strictly a price-related decision. Our fundamentals are solid. They're growing.
That is Craig Ridenhour, the president, trying to separate the operating company from the stock. He is partly right. The clearing operation is functioning and the capital is real. But the share price is not a cosmetic issue for a company that still needs to close acquisitions and raise capital. Management knows it. John Schaible, the executive chairman, put the valuation gap in blunt terms: “At $0.07 per share, our market capitalization is about half of our $20.7 million of stockholders' equity.” — John Schaible, Executive Chairman · 2026-11-16
A company-specific crisis, not a market theme
This is not a name riding a broad wave. The global keyword map is full of tariffs, Fed-rate debates, AI infrastructure, and election-related noise; AtlasClear's top themes are insular: NYSE American, appeal process, share price, Ark Financial Services, and stock price. There is no sector-wide clearing or brokerage catalyst in the global tape doing the work here. The company is fighting its own listing.
The contrast with prior calls is stark. A year ago, management was reassuring investors that NYSE American had no dollar threshold that mattered. Craig said then: “We are on NYSE American, and they have no dollar threshold as a listing standard right now. So we are fine.” — David Ridenhour, President · 2025-11-14 That was true then and obsolete now. The exchange has since moved against the stock, and the company is pursuing an appeal while preparing a reverse split. The new keyword set—appeal process, reverse, Exchange, trading—is the clearest signal of what changed this quarter. It is not the revenue line.
The Ark Financial Services transaction also looks different than the prior call implied. In September, John said he was “optimistic that Dawson James transaction will be closed very soon.” — John Schaible, Executive Chairman · 2026-09-24 What actually happened in October was a definitive agreement to acquire Ark, the parent of Dawson James, plus an initial 24.9% stake for $2.5 million cash and a $2.5 million seller note. The remaining 75.1% still needs FINRA approval of the continuing membership application, plus stockholder approval to the extent required. So the deal has moved from "soon" to "signed but structurally incomplete." The company did use independent valuation advisers and recused the conflicted director, which is the right process. But the closing risk has not disappeared; it has been reclassified.
The recurring promises: stock locate, correspondents, and delayed markers
The most credible part of the story is stock locate. It was the surprise revenue line a year ago. On the prior call, John said the company “do fully anticipate that, that will grow” — John Schaible, Executive Chairman · 2026-09-24 as the team mined latent business and expanded the LocBox relationship. That has happened. This quarter, Craig called it sustainable and said the company is “just scratching the surface.” — David Ridenhour, President · 2026-11-16 For once, the follow-through matches the prior enthusiasm.
The correspondent ramp is less satisfying. Last quarter, management said three of six signed correspondents were fully integrated, with the other three expected by year-end. Now the count is nine signed agreements, four added since July, but the new relationships are not yet a meaningful revenue contributor. Craig pushed the marker out again: “we do believe, especially going into the first quarter of actually calendar year '27 for the Street, that we'll start to recognize significant revenue from the correspondents that we've brought on.” — David Ridenhour, President · 2026-11-16 That is a specific, testable promise—and it is later than the prior call's framing. Investors should hold management to it.
The cost side explains why the P&L still shows a $1.1 million net loss. John said the company has been “increasing our staff, increasing our technology scope, increasing our compliance capacities, investing in AI solutions.” — John Schaible, Executive Chairman · 2026-11-16 Compensation costs fell 13%, which is the operating-leverage argument in miniature: more revenue without more people. But the fixed build-out is real. The prior call framed roughly $14 million of operating cost as the inflection threshold; the company is still spending to get above it.
The balance sheet is not the problem. Effective net cash was about $26 million, and liabilities were 70% of assets, down from over 100% in 2025. The BMO line remains undrawn. Revenue has grown from roughly $3 million to $7 million on a trailing basis. At 1.5x price-to-revenue, the market is not paying for growth; it is pricing delisting risk and dilution.
What would make the equity work again
The near-term setup is binary and procedural, not fundamental. First, the appeal and reverse split need to restore an NYSE American listing and a price above the danger zone. Second, FINRA needs to clear the Dawson James continuing membership application so Ark can be consolidated. Third, Commercial Bancorp of Wyoming needs to be refiled—management now says "timely" in the first quarter after pulling back to add consultants, another marker that has slipped from prior calls. Fourth, the signed correspondents need to convert into actual clearing revenue in calendar Q1 2027.
If those happen, AtlasClear could look cheap: a clearing platform with $15 million of net capital, a profitable acquisition target, and a market cap below book. If they do not, the reverse split becomes a Band-Aid on an OTC story. John said the company has “multiple term sheets that are in negotiation for capital funding” — John Schaible, Executive Chairman · 2026-11-16 and is trying to avoid an ATM or equity line. That is the right instinct, but it also means the stock price is now an operating variable: it determines the currency for the Ark remainder and the terms of any raise.
The business is more real than the stock price suggests. The stock is also more fragile than the business headlines suggest. That tension—not a new market theme—is the AtlasClear story.